UltrasonIQ® - enhancing precision, safety and efficacy in medication administration.

1.52B

Globally 65yrs+
by 2050

590M

Dysphagia sufferers
World-wide

>98%+

Medication dose
delivery

$200B+

Global Veterinary
Market

At Lifasyst, we believe the future of global health depends on smarter, more efficient therapeutic delivery.

Lifasyst’s proprietary technology UltrasonIQ® redefines how treatments are delivered to patients – human and animal – enhancing precision, safety, and efficacy in medication administration, by optimising therapeutic impact and improving health outcomes.

Lifasyst is positioned to drive measurable advances in wellness and longevity globally.

• Tube Feeding • In Home Care
• Community Care
• Aged Care • NDIS Participants
• Hospitals • Pharmacies

for more

medasyst.com

• General Veterinary Clinics
• Specialised Veterinary Clinics
• Animal Hospitals • Zoos
• Wildlife Parks

for more

vetasyst.com.au

email contact